By Duncan Bridgeman
Friday 23rd May 2003 |
Text too small? |
The 17% lift in profit was in line with expectations, pushing Healthcare shares up another 5c to $10.75 at press time yesterday.
Chief executive Michael Daniell said the company was planning a number of
significant new product introductions, including sleeping masks, humidifier systems, breathing circuits and patient warmers.
The result included realised and unrealised foreign exchange gains of $23 million after tax.
Operating revenue for the company's core product range grew 17% in US dollar terms over the previous year.
Mr Daniell said the company expected a continuation of strong US dollar revenue growth.
Fisher & Paykel makes heated humidification products for use in respiratory care and treatment of obstructive sleep apnea (OSA), a condition that stops breathing during sleep.
No comments yet
GTK - Half-Year Results Announcement Date
Government ends war on farming
Sky and BBC Studios renew expanded, multi-year agreement
AOF - Q1 Improved Trading Performance & FY24 Guidance Maintained
Devon Funds Morning Note - 23 April 2024
April 23rd Morning Report
RYM - Group CEO Update
BGI - Director Michael Chai
RAD - Final Dividend and Strong FY24 Operating Performance
RYM - Group CEO Update